Cardinal Health (BUE:CAH) Long-Term Debt: ARS10,374,346 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:CAH Cardinal Health Inc BUE:CAH
70 GF Score
Price ARS124,875.00
GF Value ARS75,542.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cardinal Health Long-Term Debt?

Cardinal Health BUE:CAH -0.10% 70 Long-Term Debt is ARS10,374,346 Mil as of Jun. 2026. GuruFocus rates BUE:CAH with a GF Score™ of 70/100 and a GF Value™ of ARS75,542.06 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Cardinal Health's Long-Term Debt for the quarter that ended in Jun. 2026 was ARS10,374,346 Mil.

Cardinal Health's quarterly Long-Term Debt declined from Dec. 2025 (ARS12,115,579 Mil) to Mar. 2026 (ARS11,528,531 Mil) and declined from Mar. 2026 (ARS11,528,531 Mil) to Jun. 2026 (ARS10,374,346 Mil).

Cardinal Health's annual Long-Term Debt increased from Jun. 2024 (ARS4,171,239 Mil) to Jun. 2025 (ARS9,470,559 Mil) and increased from Jun. 2025 (ARS9,470,559 Mil) to Jun. 2026 (ARS10,374,346 Mil).


Cardinal Health  (BUE:CAH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Cardinal Health Long-Term Debt Related Terms


Cardinal Health Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Cardinal Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardinal Health Long-Term Debt Chart

Cardinal Health Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 569,762.56 938,159.99 4,171,238.94 9,470,559.29 10,374,345.92

Cardinal Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,470,559.29 12,194,951.37 12,115,578.59 11,528,530.77 10,374,345.92
BUE:CAH
70GF Score
Cardinal Health Inc BUE:CAH
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ARS10,374,346 Mil mean?
Cardinal Health (BUE:CAH) has a Long-Term Debt of ARS10,374,346 Mil as of Jun. 2026.
Is Cardinal Health's Long-Term Debt too high?
Cardinal Health's current Long-Term Debt is ARS10,374,346 Mil. Overall, Cardinal Health has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Long-Term Debt compare to COR and HSIC?
Cardinal Health's Long-Term Debt of ARS10,374,346 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Cardinal Health's current Long-Term Debt is ARS10,374,346 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (BUE:CAH) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS75,542.06, compared to a current price of ARS124,875.00 — trading 65.3% above its estimated fair value. The current Long-Term Debt is ARS10,374,346 Mil. Cardinal Health's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Cardinal Health (BUE:CAH), the current Long-Term Debt is ARS10,374,346 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cardinal Health (BUE:CAH) Overvalued in 2026?

Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued. The current stock price of ARS124,875.00 is trading 65.3% above its estimated GF Value™ of ARS75,542.06. GuruFocus considers Cardinal Health to be Significantly Overvalued.

Key valuation signals for BUE:CAH:

  • Long-Term Debt: ARS10,374,346 Mil
  • GF Value™: ARS75,542.06 vs. price of ARS124,875.00 (65.3% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the BUE:CAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cardinal Health Business Description

Address 7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
70GF Score

Get the complete analysis for BUE:CAH

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS124,875.00
Price
ARS75,542.06
GF Value